Who is sponsoring NCT05109416?

NCT05109416 is sponsored by Minia University.

What drugs are being tested in NCT05109416?

Interventions in NCT05109416: Bupivacaine Hydrochloride 0.5% Injection Solution, Saline 0.9%.

What condition does NCT05109416 study?

NCT05109416 studies Post Tonsillectomy Pain.

Is NCT05109416 still recruiting?

NCT05109416 is currently completed. Last updated 22 April 2022.

Last reviewed 2022-04-22 · How we verify

NCT05109416

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Glossopharyngeal Nerve Block on Post Tonsillectomy Pain Among Egyptian Children

Completed Phase 1, PHASE2 Last updated 22 April 2022

What this trial tests

Phase 1, PHASE2 trial testing Bupivacaine Hydrochloride 0.5% Injection Solution in Post Tonsillectomy Pain in 210 participants. Completed in 22 March 2022.

Timeline

17 October 2021

Primary endpoint
5 March 2022

22 March 2022

Quick facts

Lead sponsor	Minia University
Phase	Phase 1, PHASE2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	210
Start date	17 October 2021
Primary completion	5 March 2022
Estimated completion	22 March 2022
Sites	1 location across Egypt

Drugs / interventions tested

Bupivacaine Hydrochloride 0.5% Injection Solution
Saline 0.9% — full drug profile →

Conditions studied

Post Tonsillectomy Pain — all drugs for Post Tonsillectomy Pain →

Sponsor

Minia University

Who can join

Adults 7 to 15, any sex, with Post Tonsillectomy Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Tonsillectomy is one of most common performed surgical procedure in children . tonsillectomy or adenotonsillectomy have high incidence of Post operative pain , it is very important and significant problem because it can lead to decrease oral intake and dehydration

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Minia University trials

Trials by the same sponsor.

NCT07525687 — Temporary Uterine Tourniquet Application Versus Local Myometrial Epinephrine Injection During Laparoscopic Myomectomy · NA · not yet recruiting
NCT07525674 — Vacuum Sealing Drainage (VSD) in Promoting Wound Healing and Reducing Complications in Post-Infected Obstetric and Gynec · NA · not yet recruiting
NCT07529587 — Laparoscopic Umbilico-uterine Trunk Clipping Approach in the Management of Enhanced Myometrial Vascularity · NA · not yet recruiting
NCT07500558 — Ultrasound Guided Infratemporal Sphenopalatine Ganglion Supravoltage Versus Standard Voltage Pulsed Radiofrequency for P · NA · not yet recruiting
NCT07428057 — Postoperative Hypocalcemia After Thyroidectomy · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05109416 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Minia University
Last refreshed: 22 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05109416.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing